Biosig Technologies Inc
NASDAQ:STEX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Biosig Technologies Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Biosig Technologies Does
Biosig Technologies is a medical technology company that builds tools for cardiac electrophysiology, the specialty that studies and treats abnormal heart rhythms. Its main product is the PURE EP system, a recording and signal-processing platform used in hospital electrophysiology labs during procedures such as mapping and ablation. The company focuses on making the heart’s electrical signals clearer so doctors can work with more usable data.
- Headquarters
- United States of America US
- Employees
- 50
- IPO date
- Sep 22, 2014
Balance Sheet
Recent Events
Latest Earnings Call
Streamex is positioning itself as a tokenized-commodities platform, extending GLDY through new distribution channels and Cask Foundation products while introducing a new brand.
Open the earnings call- EPS
- −$0.09
- Expected
- −$0.03
- Surprise
- −200.0%
- Stock, next trading day
- +3.2%
Biosig Technologies insiders made their first purchases in five years
Past 12 months
Continue STEX Research
Decided on Biosig Technologies? Get an email when STEX reaches the price you’d buy at. Free with an account.